Skip to main content
. 2020 Feb 28;4(2):78–83. doi: 10.1093/jcag/gwaa007

Table 2.

Procedural characteristics and outcomes for 895 ERCP procedures

Characteristics Number of procedures (%)
Targeted duct
 CBD 813 (90.8)
 PD 63 (7.0)
 Both 10 (1.1)
Total cannulation attempts*
 1 or 2 238 (43.6)
 3–5 103 (18.9)
 6–10 52 (9.5)
 Greater than 10 86 (15.8)
Cannulation time, minutes—mean (SD)* 5.12 (8.21)
Pancreatic duct cannulation or double wire usage 153 (29.9)
Maneuvers performed*
 Standard sphincterotomy 484 (88.6)
 Balloon sphincteroplasty 99 (18.1)
 Precut sphincterotomy (any kind) 100 (18.3)
 Needle-knife papillotomy 61 (11.2)
Cholangioscopy performed 24 (2.7)
Pancreatoscopy performed 2 (0.2)
Procedure time, minutes—mean (SD) 25.0 (16.5)
General anaesthesia used
 Yes 107 (12.0)
 No 788 (88.0)
Mean doses of sedating medications used
 Midazolam, mg IV—mean (SD) 5.53 (7.39)
 Fentanyl, µg IV—mean (SD) 94.25 (38.76)
 Diphenhydramine, mg IV—mean (SD) 46.87 (9.61)
Procedural success 806 (90.1)
Reasons for procedural failure
 Sedation-related issues 4 (0.4)
 Inability to locate papilla of interest 5 (0.6)
 Inability to cannulate duct of interest 46 (5.1)
 Inability to clear duct of interest or relieve obstruction 37 (4.1)
Stent(s) placed in CBD 85 (9.5)

CBD Common bile duct; IV Intravenous; PD Pancreatic duct; SD Standard deviation.

*Calculated only from 546 procedures with native papillae; calculated only from procedures with native papillae where the CBD was the target, n = 512; calculated only from procedures where conscious sedation was used, n = 788.